Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desferrioxamine for acute STEMI
ACTRN12608000308392Phase 4Completed
- Sponsor
- The Alfred Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) and coronary arteriosclerosis comparing Desferrioxamine with Placebo (2 arms). Primary endpoints: Myocardial infarct size by cardiac magnetic resonance imaging, Myocardial infarct size by cardiac biomarkers and ST-segment resolution and 1 more. Started Jun 2008; status: completed.
02
Drugs
deferoxamine
03
Conditions
myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12608000308392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000308392.